164 related articles for article (PubMed ID: 18598734)
1. The potential health and economic benefits of preventing recurrent respiratory papillomatosis through quadrivalent human papillomavirus vaccination.
Chesson HW; Forhan SE; Gottlieb SL; Markowitz LE
Vaccine; 2008 Aug; 26(35):4513-8. PubMed ID: 18598734
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of male HPV vaccination in the United States.
Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
Vaccine; 2011 Oct; 29(46):8443-50. PubMed ID: 21816193
[TBL] [Abstract][Full Text] [Related]
3. Prevention of recurrent respiratory papillomatosis: role of HPV vaccination.
Freed GL; Derkay CS
Int J Pediatr Otorhinolaryngol; 2006 Oct; 70(10):1799-803. PubMed ID: 16884786
[TBL] [Abstract][Full Text] [Related]
4. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
[TBL] [Abstract][Full Text] [Related]
5. Recurrent respiratory papillomatosis: an uncommon but potentially devastating effect of human papillomavirus in children.
Donne AJ; Clarke R
Int J STD AIDS; 2010 Jun; 21(6):381-5. PubMed ID: 20606216
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening.
Thiry N; De Laet C; Hulstaert F; Neyt M; Huybrechts M; Cleemput I
Int J Technol Assess Health Care; 2009 Apr; 25(2):161-70. PubMed ID: 19366497
[TBL] [Abstract][Full Text] [Related]
7. Mathematical models of cervical cancer prevention in the Asia Pacific region.
Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ
Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of recurrent respiratory papillomatosis.
Larson DA; Derkay CS
APMIS; 2010 Jun; 118(6-7):450-4. PubMed ID: 20553527
[TBL] [Abstract][Full Text] [Related]
9. Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term observation.
Gerein V; Schmandt S; Babkina N; Barysik N; Coerdt W; Pfister H
Cancer Detect Prev; 2007; 31(4):276-81. PubMed ID: 17935912
[TBL] [Abstract][Full Text] [Related]
10. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
Armstrong GL; Billah K; Rein DB; Hicks KA; Wirth KE; Bell BP
Pediatrics; 2007 Jan; 119(1):e22-9. PubMed ID: 17200247
[TBL] [Abstract][Full Text] [Related]
11. Recurrent respiratory papillomatosis: update 2008.
Gallagher TQ; Derkay CS
Curr Opin Otolaryngol Head Neck Surg; 2008 Dec; 16(6):536-42. PubMed ID: 19005325
[TBL] [Abstract][Full Text] [Related]
12. Health and economic impact associated with a quadrivalent HPV vaccine in Italy.
Mennini FS; Giorgi Rossi P; Palazzo F; Largeron N
Gynecol Oncol; 2009 Feb; 112(2):370-6. PubMed ID: 19041125
[TBL] [Abstract][Full Text] [Related]
13. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis.
Kashima HK; Shah F; Lyles A; Glackin R; Muhammad N; Turner L; Van Zandt S; Whitt S; Shah K
Laryngoscope; 1992 Jan; 102(1):9-13. PubMed ID: 1309932
[TBL] [Abstract][Full Text] [Related]
14. Anti-HPV vaccination: a review of recent economic data for Italy.
Mennini FS; Costa S; Favato G; Picardo M
Vaccine; 2009 May; 27 Suppl 1():A54-61. PubMed ID: 19480963
[TBL] [Abstract][Full Text] [Related]
15. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.
Lacey CJ; Lowndes CM; Shah KV
Vaccine; 2006 Aug; 24 Suppl 3():S3/35-41. PubMed ID: 16950016
[TBL] [Abstract][Full Text] [Related]
16. Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study.
Novakovic D; Cheng AT; Cope DH; Brotherton JM
Sex Health; 2010 Sep; 7(3):253-61. PubMed ID: 20719212
[TBL] [Abstract][Full Text] [Related]
17. Mathematical models of cervical cancer prevention in Latin America and the Caribbean.
Goldie SJ; Diaz M; Constenla D; Alvis N; Andrus JK; Kim SY
Vaccine; 2008 Aug; 26 Suppl 11():L59-72. PubMed ID: 18945403
[TBL] [Abstract][Full Text] [Related]
18. The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients.
Wong G; Howard K; Webster A; Chapman JR; Craig JC
Transplantation; 2009 Apr; 87(7):1078-91. PubMed ID: 19352131
[TBL] [Abstract][Full Text] [Related]
19. Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons.
Nichol KL; Nordin J; Mullooly J
Vaccine; 2006 Mar; 24(10):1562-8. PubMed ID: 16300868
[TBL] [Abstract][Full Text] [Related]
20. Do human papillomavirus vaccines have any role in newborns and the prevention of recurrent respiratory papillomatosis in children?
Schaffer A; Brotherton J; Booy R
J Paediatr Child Health; 2007 Sep; 43(9):579-80. PubMed ID: 17688640
[No Abstract] [Full Text] [Related]
[Next] [New Search]
